Clinical Trials Office
Running successful clinical trials requires highly ethical, organized and experienced personnel. The Clinical Trials Office, led by Ari VanderWalde, MD, MPH, Director of Clinical Research at West Cancer Center and Associate Vice Chancellor of Research at the University of Tennessee Health Science Center, helps to support, augment and expand high-quality and high-impact clinical trial offerings. The office is also responsible for aligning processes related to pharmaceutical studies, recruiting staff to support strategic research initiatives, and organizing the infrastructure to support clinical research.
To learn more about Clinical Trial offerings at West Cancer Center, click here.
Tissue and Biospecimen Services
The Special Histology Laboratory at the University of Tennessee Health Science Center is fully equipped for tissue processing, embedding, cutting and staining histology slides. Highly trained and experienced histology technicians are able to process requests quickly and competently.
For more information the Special Histology Services, click here.
Xenograft Core Facility
The Xenograft Core Facility is a specialized research facility that provides a variety of advanced xenograft services to academic and industry investigators. The facility is located in the Center for Cancer Research at the University of Tennessee Health Science Center.
For more information on the Xenograft Core Facility, click here.
Biostatistics and Biomedical Information
The UT/West Institute for Cancer Research and the Biostatistics, Epidemiology, and Research Design (BERD) Unit of iRISE have launched a new service for UT/West Cancer Center grant recipients and investigators. Researchers covered under this program are eligible to use both the BERD Clinic and the biostatistics consulting service free of charge. To access the BERD Clinic, investigators should reserve a timeslot on the iRISE website; the clinic is available at three locations on the UT campus, and online through Zoom web conferencing (“Virtual BERD”). It is recommended that investigators visit the BERD Clinic to obtain advice on study design and their statistical analysis planning early in their research process.
To access consulting services, investigators should first visit the BERD Clinic to meet with a biostatistician and draw up a scope of work. On this initial visit please indicate your affiliation with West Cancer Center. After the scope of work has been approved by the investigator and the West Cancer Center Research Subcommittee the project can begin.